Nexalin Technology (NXL) Profit After Tax (2021 - 2026)
Nexalin Technology (NXL) posted Profit After Tax of -$2.2 million for Q2 2026, down 6.81% on a QoQ basis from -$2.1 million in Q1 2026, and down 41.66% year-over-year from -$3.8 million in Q2 2025.
Analysis
Nexalin Technology (NXL) Profit After Tax (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Profit After Tax for 6 years, with the latest figure at -$2.2 million in Q2 2026.
- On a quarterly basis, Profit After Tax fell 41.66% year-over-year to -$2.2 million in Q2 2026; TTM through Jun 2026 was -$9.0 million, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at -$8.2 million, down 8.08% from the prior year.
- Profit After Tax was -$2.2 million for Q2 2026 at Nexalin Technology, down from -$2.1 million in the prior quarter.
- The five-year high for Profit After Tax was -$135401.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
- Average Profit After Tax over 5 years is -$1.5 million, with a median of -$1.4 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 92.48% in 2022, then plunged 1620.43% in 2023.
- Over 5 years, Profit After Tax stood at -$729677.0 in 2022, then fell by 7.15% to -$781874.0 in 2023, then plunged by 262.38% to -$2.8 million in 2024, then gained by 16.13% to -$2.4 million in 2025, then increased by 5.76% to -$2.2 million in 2026.
- The last three Profit After Tax figures came in at -$2.2 million (Q2 2026), -$2.1 million (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | -2.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.24 Mn |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.45 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | -781,874.00 |
| Sep 30, 2023 | -2.33 Mn |
| Jun 30, 2023 | -830,417.00 |
| Mar 31, 2023 | -748,414.00 |
| Dec 31, 2022 | -729,677.00 |
| Sep 30, 2022 | -135,401.00 |
| Jun 30, 2022 | -462,405.00 |
| Mar 31, 2022 | -393,249.00 |
| Dec 31, 2021 | -595,928.00 |
| Sep 30, 2021 | -1.80 Mn |